Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model

Osteoporosis (OP) is a highly prevalent orthopedic condition in postmenopausal women and the elderly. Currently, OP treatments mainly include bisphosphonates, receptor activator of nuclear factor kappa-B ligand (RANKL) antibody therapy, selective estrogen receptor modulators, teriparatide (PTH1-34),...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oxid Med Cell Longev
Main Authors: Yang, Lang, Fan, Liuyi, Wang, Kexin, Chen, Yupeng, Liang, Lan, Qin, Xuemei, Lu, Aiping, Cao, Peng, Yu, Bin, Guan, Daogang, Peng, Junxiang
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238601/
https://ncbi.nlm.nih.gov/pubmed/34239693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6641838
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares